Consensus Celldex Therapeutics, Inc.

Equities

CLDX

US15117B2025

Market Closed - Nasdaq Other stock markets 21:00:00 29/04/2024 BST			5-day change	1st Jan Change
37 ^USD	+1.93%		-4.76%	-6.71%

04-17	Sector Update: Health Care Stocks Mixed Wednesday Afternoon	MT
04-17	Celldex Therapeutics Says Patient Enrollment Completed in Chronic Inducible Urticaria Treatment Study; Shares Rise	MT

Evolution of the average Target Price on Celldex Therapeutics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

2676.g_mONRoaz8RzxPGQDb0diXOgwTscj0flyVLijp2dg-0.saqjGE99obNF9rjzOc1F3D2Yj21k9SmGiDa4zMv4yI_hwMkCdFKcgiKOsA~93700bfa06dcfc80d847415d09b47474

Analyst Recommendations on Celldex Therapeutics, Inc.

TD Cowen Initiates Celldex Therapeutics at Outperform Rating	12-20	MT
Wells Fargo Upgrades Celldex Therapeutics to Equalweight From Underweight With $27 Price Target	11-10	MT
HC Wainwright Adjusts Price Target on Celldex Therapeutics to $80 From $73, Maintains Buy Rating	11-06	MT
Rate Cut Hopes Push Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday	11-06	MT
Wells Fargo Starts Celldex Therapeutics With Underweight Rating, $21 Price Target	22/08/23	MT
ANALYST RECOMMENDATIONS : Applovin, BAE Systems, Evercore, Jefferies, Target...	22/08/23
Guggenheim Adjusts Price Target on Celldex Therapeutics to $63 From $68, Maintains Buy Rating	11/11/22	MT
SVB Securities Adjusts Celldex Therapeutics' Price Target to $64 From $68, Keeps Outperform Rating	09/08/22	MT
HC Wainwright Adjusts Celldex Therapeutics' Price Target to $73 from $60, Keeps Buy Rating	01/07/22	MT
CELLDEX THERAPEUTICS : Jefferies & Co Reinstates Coverage on Celldex Therapeutics With Buy Rating, $66 Price Target	17/09/21	MT
ANALYST RECOMMENDATIONS : Autoliv, Fortinet, Tesla, Virgin Galactic, WP Carey...	17/09/21
CELLDEX THERAPEUTICS : HC Wainwright Adjusts Celldex Therapeutics PT to $60 From $54, Maintains Buy Rating	13/09/21	MT
CELLDEX THERAPEUTICS : SVB Leerink Starts Celldex Therapeutics at Outperform with $68 Price Target	10/09/21	MT
CELLDEX THERAPEUTICS : HC Wainwright Adjusts Celldex Therapeutics' Price Target to $54 From $50, Reiterates Buy Rating	06/08/21	MT
CELLDEX THERAPEUTICS : Guggenheim Starts Celldex Therapeutics at Buy With $66 Price Target	22/07/21	MT
CELLDEX THERAPEUTICS : HC Wainwright Adjusts Price Target on Celldex Therapeutics to $50 From $36, Reiterates Buy Rating	12/07/21	MT
Celldex Therapeutics : Reports 80% Complete Response Rate in CDX-0159 Study	29/03/21	MT
Celldex Reports 80% Complete Response Rate in Interim Data Update from Phase 1b study of CDX-0159 in Chronic Inducible Urticaria	29/03/21	CI
CELLDEX THERAPEUTICS : HC Wainwright & Co. Adjusts Price Target on Celldex Therapeutics to $36 From $25, Maintains Buy Rating	23/02/21	MT
CELLDEX THERAPEUTICS : Cantor Fitzgerald Adjusts Celldex Therapeutics PT to $35 From $22, Maintains Overweight Rating	23/02/21	MT
Celldex Therapeutics, Inc. Announces Positive Results from a Phase 1 Multi-Dose Study of CDX-301	11/12/12	CI